GFAP and Alzheimer disease: It has been hypothesized that throughout the AD continuum, neuroinflammatory biomarkers in blood and CSF exhibit a complex temporal progression, with distinct profiles for CSF and blood sTREM2, GFAP, and YKL-40 [168] (Fig. 3).